The global blood glucose monitoring systems market is expected to grow at a CAGR of 6.5% during the forecast period (2022-2028). According to International Diabetes Federation, more than 460 million people suffering from diabetes in 2019 and this figure is estimated to reach 700 million by 2045. Thus, the monitoring of blood glucose level is important for diabetes patients. Conventional devices for glucose monitoring require a small amount of blood to be drawn out of the body by needle insertion in the skin. It often causes discomfort and pain after repeated use and poses risks of potential infection and tissue damage. As a result, there has been a continuous effort for developing non-invasive and minimally-invasive devices, aimed at reducing some of the issues connected with the traditional invasive methods.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/blood-glucose-monitoring-systems-market
Further, traditional blood glucose monitoring systems show glucose levels only at a specific point in time which has limited value as the user cannot estimate the glucose levels before or in the hours after the test. The non-invasive and minimum invasive AI-enabled devices capture readings every fraction of minutes, record the highs and lows, and monitor time in range, thus enabling people to observe how their glucose levels are fluctuating through the day. Thus, all these factors have led to the growing demand for innovative devices with minimally or non-invasive technologies.
Several players have come forward with innovative devices and overcome the concerns faced by traditional devices. For instance, in January 2022, Health-tech startup BlueSemi launched Eyva, a non-invasive glucometer for diabetics that can provide results without any pricking or needles. The device uses sensor technology to be able to record the glucose molecules inside the body. In November 2020, Abbott laboratories launched the FreeStyle Libre system in India. It is a continuous glucose monitoring device which tracks blood glucose levels in blood with the minimum invasive method. In 2019, Nemaura, a UK-based medical technology company launched, sugarBEAT wearable sensor platform, which received C.E. approval 2019 and is a non-invasive CGM (Continuous Glucose Monitor) where the sensor is attached to the upper arm. It is a non-invasive device and does not require the sensor to be inserted inside the skin. The user can monitor glucose levels through the wearable sensor in real-time without having to scan the device or any other intervention. After its launch in Europe, Nemaura is further planning launches in Germany, Saudi Arabia and UAE.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Product
o By Application
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Abbott Laboratories, B. Braun Melsungen AG, Dexcom, Inc., F. Hoffman-La Roche Ltd., and Sanofi S.A.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Blood Glucose Monitoring Systems Market Report by Segment
By Product
Self-Monitoring Blood Glucose System
o Blood Glucose Meters
o Testing Strips
o Lancets
Continuous Glucose Monitoring System
o Sensors
o Transmitters
o Receiver
By Application
- Type 1 Diabetes
- Type 2 Diabetes
By End-User
- Hospitals
- Home Care
- Diagnostics Center
A full report of Blood Glucose Monitoring Systems Market is available at: https://www.omrglobal.com/industry-reports/blood-glucose-monitoring-systems-market
Blood Glucose Monitoring Systems Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Acon Labs Inc.
- AgaMatrix, Inc.
- Arkray, Inc.
- Ascensia Diabetes Care Holdings AG
- GlySens Inc.
- Insulet Corp.
- Medtronic plc
- Nipro Corp.
- Nova Biomedical
- Novo Nordisk A/S
- Prodigy Diabetes Care, LLC
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research